Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1846)	2/22/2008 2:49:07 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

COR is up 12.% on volume of 125,850 still < its ADV,with no news that I am aware. bigcharts.marketwatch.com The insiders did some buying in Nov, Dec & Jan & the stock seems to have found support at the $0.44 level. On Oct 11 was when the stock price was cut in > half after it reported that the FDA had rejected its request to run a PII for its CX717 due to toxicity concerns. COR had sought to test the CX717 for the treatment of attention deficit hyperactivity disorder & said that it still had plans to continue developing CX717 for other disorders, including respiratory depression and AD.<g> It seems that the stock wants to get back to the $1 level. If it could close some of its Oct 11 DG it would be a good gain from present levels.<g> bigcharts.marketwatch.com Bernard